{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:21:13Z","timestamp":1791584473646,"version":"4.3.4"},"reference-count":0,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2000,1,1]],"date-time":"2000-01-01T00:00:00Z","timestamp":946684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Ophthalmology"],"published-print":{"date-parts":[[2000,1]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To investigate whether commonly used vasodilating drugs ameliorate angiogenesis in experimental retinopathy of prematurity (ROP), and to study the response of these drugs to different growth factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used a rat and mouse model of oxygen-induced ischemic retinopathy. Animals were treated with nimodipine, gingko-biloba and dipyridamole intraperitoneally starting the day before exposure to room air (day 1). Controls were injected with vehicle solution only. Eyes were processed histopathologically with serial sections and neovascularization was measured by counting the nuclei within the retinal internal limiting membrane, by a masked observer. Retinal and vitreous tissues were assayed by ELISA for VEGF, PDGF and TGF\u03b22.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Nimodipine significantly inhibited the growth of new vessels in rats. The number of nuclei was 310 \u00b1 69 in the control group (n:14) and 121 \u00b1 53 in the treated ones (n:14), (p&lt;0.0005). Similar results were found with ginkgo-biloba extracts: 344 \u00b1 53 (n:15) in controls, and 136 \u00b1 29 (n:11) in treated ones (p&lt;0.0005), and with dipyridamole: 303 \u00b1 69 (n:13) in controls, and 131 \u00b1 48.5 in treated rats (p&lt;0.0005). Results were similar in mice. 186 \u00b1 45 (n:7) nuclei counted in controls against 90 \u00b1 25 (n:6) for dipyridamole treated (p&lt;0.0005); and 81 \u00b1 21 for ginkgo-biloba treated animals (p&lt;0.0005). A gradual, very significant increase in VEGF values in response to relative hypoxia (room air) contrasted with the significant inhibition noted both with ginkgo-biloba extracts and dipyridamole. TGF\u03b22 and PDGF both showed a gradual increase in relative hypoxia at days 2 and 4 of room air (p&lt;0.0005). Treated animals showed marked inhibition of the three growth factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>All three drugs markedly inhibited angiogenesis in experimental ROP. Growth factors were elevated in hypoxic conditions. Treated animals showed significant decreases of PDGF, VEGF, and TGF\u03b22 in retinal and vitreous tissues.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/112067210001000109","type":"journal-article","created":{"date-parts":[[2018,1,24]],"date-time":"2018-01-24T11:12:17Z","timestamp":1516792337000},"page":"51-59","source":"Crossref","is-referenced-by-count":27,"title":["Experimental Retinopathy of Prematurity: Angiostatic Inhibition by Nimodipine, Ginkgo-Biloba, and Dipyridamole, and Response to Different Growth Factors"],"prefix":"10.1177","volume":"10","author":[{"given":"C.P.","family":"Ju\u00e1rez","sequence":"first","affiliation":[{"name":"Fundaci\u00f3n VER, C\u00f3rdoba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.","family":"Mui\u00f1o","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3n VER, C\u00f3rdoba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Guglielmone","sequence":"additional","affiliation":[{"name":"L.A.C.E. Laboratories, C\u00f3rdoba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Sambuelli","sequence":"additional","affiliation":[{"name":"Catholic University of C\u00f3rdoba, C\u00f3rdoba - Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.R.","family":"Echenique","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3n VER, C\u00f3rdoba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3n VER, C\u00f3rdoba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.D.","family":"Luna","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3n VER, C\u00f3rdoba"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2000,1,1]]},"container-title":["European Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/112067210001000109","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/112067210001000109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T19:38:15Z","timestamp":1777405095000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/112067210001000109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,1]]}},"alternative-id":["10.1177\/112067210001000109"],"URL":"https:\/\/doi.org\/10.1177\/112067210001000109","relation":{},"ISSN":["1120-6721","1724-6016"],"issn-type":[{"value":"1120-6721","type":"print"},{"value":"1724-6016","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,1]]}}}